Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg. [electronic resource]
Producer: 20091009Description: 967-78 p. digitalISSN:- 1365-2036
- 2-Pyridinylmethylsulfinylbenzimidazoles -- administration & dosage
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Ulcer Agents -- therapeutic use
- Dose-Response Relationship, Drug
- Double-Blind Method
- Esomeprazole -- administration & dosage
- Female
- Gastroesophageal Reflux -- drug therapy
- Heartburn -- drug therapy
- Helicobacter Infections -- drug therapy
- Helicobacter pylori
- Humans
- Male
- Middle Aged
- Primary Health Care
- Rabeprazole
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.